ArticleCell death discovery2025
Insufficient NNMT promotes autophagy and disrupts progesterone signaling in endometrial stromal cells in recurrent implantation failure by modulating the H3K9me3-ALDH1A3 pathway.
Article in Cell death discovery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Defective endometrial receptivity represents an important factor in recurrent implantation failure (RIF), though its precise regulatory mechanisms remain unclear. While nicotinamide N-methyltransferase (NNMT) is abundantly expressed in human endometrial tissues, its role in endometrial receptivity and RIF pathogenesis has not been defined. This study demonstrated that NNMT expression was significantly downregulated in midluteal-phase endometrium from RIF patients relative to fertile controls. Functional analyses in human endometrial stromal cells (ESCs) revealed that NNMT knockdown enhanced autophagy flux and disrupted progesterone signaling. Mechanistically, NNMT deficiency elevated H3K9me3 enrichment at the Aldh1a3 promoter, suppressing its expression. Notably, knockdown of ALDH1A3 resulted in similar effects with NNMT downregulation, and exogenous rhALDH1A3 reversed the autophagy alterations and rescued progesterone signaling in NNMT-knockdown cells. In vivo, NNMT inhibition in a murine model reduced embryo implantation rates and decreased ALDH1A3 expression. Collectively, these findings indicate that reduced NNMT impairs endometrial receptivity through H3K9me3-mediated ALDH1A3 repression, leading to aberrant autophagy and disrupted progesterone signaling in decidualized ESCs. This study identifies the NNMT-H3K9me3-ALDH1A3 axis as a key epigenetic-metabolic pathway underlying RIF, offering novel diagnostic and therapeutic targets.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.